Insulin–Mimetic Dihydroxanthyletin-Type Coumarins from Angelica decursiva with Protein Tyrosine Phosphatase 1B and α-Glucosidase Inhibitory Activities and Docking Studies of Their Molecular Mechanisms

Abstract

As a traditional medicine, Angelica decursiva has been used for the treatment of many diseases. The goal of this study was to evaluate the potential of four natural major dihydroxanthyletin-type coumarins—(+)-trans-decursidinol, Pd-C-I, Pd-C-II, and Pd-C-III—to inhibit the enzymes, protein tyrosine phosphatase 1B (PTP1B) and α-glucosidase. In the kinetic study of the PTP1B enzyme’s inhibition, we found that (+)-trans-decursidinol, Pd-C-I, and Pd-C-II led to competitive inhibition, while Pd-C-III displayed mixed-type inhibition. Moreover, (+)-trans-decursidinol exhibited competitive-type, and Pd-C-I and Pd-C-II mixed-type, while Pd-C-III showed non-competitive type inhibition of α-glucosidase. Docking simulations of these coumarins showed negative binding energies and a similar proximity to residues in the PTP1B and α-glucosidase binding pocket, which means they are closely connected and strongly binding with the active enzyme site. In addition, dihydroxanthyletin-type coumarins are up to 40 µM non-toxic in HepG2 cells and have substantially increased glucose uptake and decreased expression of PTP1B in insulin-resistant HepG2 cells. Further, coumarins inhibited ONOO−-mediated albumin nitration and scavenged peroxynitrite (ONOO−), and reactive oxygen species (ROS). Our overall findings showed that dihydroxanthyletin-type coumarins derived from A. decursiva is used as a dual inhibitor for enzymes, such as PTP1B and α-glucosidase, as well as for insulin susceptibility.

Angelica sinensis polysaccharide promotes the proliferation and osteogenic differentiation of human dental pulp stem cells (hDPSCs) by activating the wnt/β-catenin pathway

“…In this study, we found its effects on the proliferation and osteogenesis differentiation of hDP-SCs. These studies confirmed that ASP played key roles in combating multiple types of diseases (Ali et al, 2021).…”

A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect

“…Docking studies with dihydroxanthyletin-type coumarins—(+)-trans-decursidinol showed that they preferably bound with the active site of Protein Tyrosine Phosphatase 1B. 81 …”

“…Docking studies with dihydroxanthyletin-type coumarins-(+)-transdecursidinol showed that they preferably bound with the active site of Protein Tyrosine Phosphatase 1B. 81 Coumarin-cyclic imide conjugates increased the glucose absorption rate to a level that is comparable to metformin in cultured hepatic carcinoma and kidney cells. 82 The furanocoumarin ficusin significantly improved the cellular uptake through the translocation and activation of GLUT4 in the plasma membranes of adipose tissue of diabetic rats.…”

In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone Helichrysum petiolare Extract (AAHPE) with Molecular Docking Relevance in Diabetes Mellitus

“…Reducing hepatic glucose generation, increasing insulin production and sensitivity, inhibiting gluconeogenesis, and decreasing glucose absorption are important targets employed in developing synthetic anti-diabetic agents. However, limitations and side effects, such as weight gain, gastrointestinal disorders, headache, peripheral oedema, and hypotension, associated with using these synthetic agents, the cost, and accessibility remain major hindrances [ 45 , 46 ]. Hydrolysis of complex starch, oligosaccharides, and disaccharides by the pancreatic α-amylase, together with glucose uptake by the intestinal α-glucosidase, have been implicated in the postprandial glucose level in type 2 diabetes [ 47 ] with its attendant complications.…”